Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ian T. Clark Other companies: Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); BioMarin Pharmaceutical Inc. (Chair of the Board, · Since at least Aug 1, 2025); GoodRx Holdings, Inc. (Director · Since at least Jul 8, 2024); Kyverna Therapeutics, Inc. (Independent Director · Since at least Feb 7, 2024); Guardant Health, Inc. (Director · Since at least Oct 3, 2018); Corvus Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2017); Forty Seven Inc (Director · Jun 27, 2018 – Apr 7, 2020 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 6, 2023 · Past); Kite Pharma Inc (Director · Jan 3, 2017 – Oct 3, 2017 · Past); Agios Pharmaceuticals, Inc. (Director · Dec 30, 2016 – May 20, 2022 · Past); Terravia Holdings Inc (Director · May 26, 2011 – May 22, 2017 · Past); Dendreon Corp (Director · Oct 7, 2009 – Aug 20, 2010 · Past); Genentech Inc (EVP-COMMERCIAL · Sep 20, 2006 – Mar 26, 2009 · Past) | Director · Since at least Aug 12, 2020 |
| Scott Garland Other companies: Enliven Therapeutics, Inc. (Member of the Board of Directors · Since at least Jan 7, 2026); LB Pharmaceuticals Inc (Chairman of the Board, LB Pharmaceuticals · Since at least Sep 10, 2025); ALX Oncology Holdings Inc. (Chairman · Since at least Nov 28, 2022); Day One Biopharmaceuticals Inc (Director · Since at least Aug 16, 2021); Calithera Biosciences, Inc. (Director · Jul 10, 2020 – Jun 1, 2022 · Past); Portola Pharmaceuticals Inc (President and CEO, Director · Oct 8, 2018 – Jul 2, 2020 · Past); Karyopharm Therapeutics Inc. (Director · Nov 3, 2014 – Jun 6, 2019 · Past); Relypsa Inc (SVP & Chief Commercial Officer · Oct 31, 2014 – Sep 1, 2016 · Past); Exelixis, Inc. (EVP & Chief Commerical Officer · Oct 20, 2011 – Sep 18, 2013 · Past) | Director · Since at least Oct 16, 2023 |
| Mark N Lampert Other companies: Immunic, Inc. (Director · Since at least Feb 17, 2026); Kymera Therapeutics, Inc. (Director · Since at least Jan 11, 2023); MoonLake Immunotherapeutics (Director · Since at least Apr 5, 2022); Rain Oncology Inc (Director · Nov 8, 2022 – Jan 25, 2024 · Past); CTi Biopharma Corp (Director · Aug 9, 2022 – Jun 26, 2023 · Past) | Director · Since at least Jun 10, 2022 |
| Sandra J. Horning Other companies: Revolution Medicines, Inc. (Director · Since at least Nov 9, 2023); Moderna, Inc. (Director · Since at least Apr 29, 2020); Gilead Sciences, Inc. (Director · Since at least Jan 28, 2020); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past); Foundation Medicine Inc (Director · Apr 7, 2015 – Apr 7, 2015 · Past) | Director · Since at least Nov 18, 2020 |
| Cynthia M. Butitta Other companies: Autolus Therapeutics plc (Chair of the Compensation Committee, Member of the Audit Committee · Since at least Mar 18, 2026); Century Therapeutics, Inc. (Director · Since at least Jun 17, 2021); UroGen Pharma Ltd. (of the Audit Committee · Since at least Jan 1, 2019); Kite Pharma Inc (Chief Operating Officer · Jun 19, 2014 – Oct 3, 2017 · Past) | Director · Since at least Aug 12, 2020 |
| Frank McCormick Other companies: BridgeBio Oncology Therapeutics, Inc. (Director · Since at least Aug 11, 2025); BridgeBio Pharma, Inc. (Director · Since at least Jun 27, 2019); Aduro Biotech Inc (Director · Apr 14, 2015 – Jun 6, 2018 · Past); Exelixis, Inc. (Director · May 2, 2006 – Dec 6, 2013 · Past) | Director · Sep 18, 2020 – Nov 23, 2020 · Past |
| John Moriarty Other companies: Kardigan, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Jun 17, 2026); Avidity Biosciences, Inc (Chief Legal Officer · Since at least Aug 1, 2024); Portola Pharmaceuticals Inc (EVP, General Counsel · Mar 12, 2018 – Jul 2, 2020 · Past); Alexion Pharmaceuticals Inc (EVP & General Counsel · Dec 10, 2012 – Feb 6, 2018 · Past) | EVP, Ch. Legal Officer & Sec. · Sep 19, 2020 – Feb 1, 2023 · Past |
| Gorjan Hrustanovic Other companies: Kymera Therapeutics, Inc. (Director · Since at least Jun 16, 2021); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past) | Director · Since at least Nov 18, 2020 |
| Jason V. O'Byrne Other companies: Vir Biotechnology, Inc. (EVP & Chief Financial Officer · Since at least Oct 2, 2024); Caribou Biosciences, Inc. (Chief Financial Officer · Jul 22, 2021 – Feb 20, 2024 · Past) | Chief Financial Officer · Since at least Aug 11, 2026 |
| Yi Larson Other companies: RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Turning Point Therapeutics Inc (EVP & Chief Financial Officer · Aug 26, 2019 – Feb 8, 2021 · Past) | Director · Since at least Apr 5, 2021 |
| Andrew Rappaport Other companies: Atheros Communications Inc (Director · Feb 7, 2006 – May 24, 2011 · Past) | Director · Since at least Sep 18, 2020 |
| G Walmsley Graham Other companies: Akero Therapeutics Inc (Director · Since at least Nov 30, 2023) | Director · Since at least Sep 12, 2023 |
| Prakash Raman Other companies: Black Diamond Therapeutics, Inc. (CEO of InduPro, Inc. · Since at least Apr 10, 2024) | Director · Since at least Apr 28, 2026 |
| Shane William Charles Kovacs Other companies: PTC Therapeutics, Inc. (Chief Financial Officer · Sep 26, 2016 – May 9, 2017 · Past) | CH. OPERATING & FINANCIAL OFF. · Since at least Jun 15, 2020 |
| Amoli Pandya | Vice President, Corporate Law · Since at least Nov 13, 2026 |
| Angelos Dovletoglou | Senior Vice President, CMC and Supply Chain · Since at least Nov 5, 2026 |
| Brad Lanoue | Vice President, Market Access · Nov 4, 2026 – Nov 13, 2026 · Past |
| Courtney O'Konek | Vice President, Corporate Communications · Since at least Nov 3, 2026 |
| Cyrus Harmon | Director · Since at least Jun 15, 2020 |
| David C. Myles | Chief Scientific Officer · Since at least Jun 15, 2020 |
| Ganesh Waghmare | Vice President, Drug Safety and Pharmacovigilance · Since at least Nov 5, 2026 |
| Gopinath Palanisamy | Vice President, Pre-Clinical Pharmacology and Toxicology · Since at least Apr 25, 2025 |
| James Wagner | Vice President, Legal Counsel · Since at least Nov 5, 2026 |
| Julie Dexter | Senior Vice President, People and Culture · Since at least Nov 5, 2026 |
| Kamesh Kuchimanchi | Senior Vice President, Regulatory Affairs · Since at least Nov 5, 2026 |
| Karen Paese | Vice President, Supply Chain · Since at least Nov 5, 2026 |
| Kate Swearingen | Vice President, Program Management · Nov 4, 2026 – Nov 13, 2026 · Past |
| Kristin Brosofsky | Vice President, Clinical Operations · Since at least Nov 5, 2026 |
| Margaret Tonda | Vice President, Clinical Science · Since at least Nov 5, 2026 |
| Mark Shilkrut | Senior Vice President, Clinical Development · Since at least Nov 5, 2026 |
| Meghna Chowdary | Senior Vice President, Commercial Strategy and Operations · Since at least Nov 5, 2026 |
| Naseem Zojwalla | Chief Medical Officer · Since at least Jan 31, 2022 |
| Rachel Wei | Vice President, Biostatistics · Since at least Nov 13, 2026 |
| Radha Iyer | Vice President, Quality Assurance · Since at least Nov 5, 2026 |
| Richard Hernandez | Senior Vice President, Clinical Operations · Since at least Nov 5, 2026 |
| Ronald E. Savage | Vice President, Clinical Pharmacology · Since at least Nov 5, 2026 |
| Sasha Austin | Vice President, Finance and Controller · Nov 4, 2026 – Nov 13, 2026 · Past |
| Sasha Lu Austin | VP of Finance and Controller · Since at least Jan 30, 2026 |
| Sean P. Bohen | President and CEO · Since at least Nov 20, 2023 |
| Shawnte M. Mitchell | Chief Legal Officer and Corporate Secretary · Since at least Feb 18, 2025 |
| Yolande Du Toit | Vice President, Medical Affairs · Since at least Nov 5, 2026 |